OTLK icon

Outlook Therapeutics
OTLK

Overview Fund Activity

27 hedge funds and large institutions have $2.79M invested in Outlook Therapeutics in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 7 increasing their positions, 1 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
27
Holders Change
+7
Holders Change %
+35%
% of All Funds
0.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
7
Reduced
1
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
LA
1
LVW Advisors
New York
$1.26M
2
Jacobs Levy Equity Management
2
Jacobs Levy Equity Management
New Jersey
$212K
3
Two Sigma Advisers
3
Two Sigma Advisers
New York
$106K
4
Vanguard Group
4
Vanguard Group
Pennsylvania
$487K
5
Two Sigma Investments
5
Two Sigma Investments
New York
$85K

Top Sellers

1
CS
1
Credit Suisse
Switzerland
$0
2
Commonwealth Equity Services
2
Commonwealth Equity Services
Massachusetts
$0
3
Squarepoint
3
Squarepoint
New York
$0
4
Cambridge Investment Research Advisors
4
Cambridge Investment Research Advisors
Iowa
$0
5
MAFM
5
Mid Atlantic Financial Management
Pennsylvania
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
CFGS
26
Concourse Financial Group Securities
Alabama
$1K – – –
CS
27
Credit Suisse
Switzerland
– -$65K -2,500 Closed
Commonwealth Equity Services
28
Commonwealth Equity Services
Massachusetts
– -$25K -1,000 Closed
Squarepoint
29
Squarepoint
New York
– -$21K -810 Closed
Cambridge Investment Research Advisors
30
Cambridge Investment Research Advisors
Iowa
– -$13K -500 Closed
MAFM
31
Mid Atlantic Financial Management
Pennsylvania
– -$13K -500 Closed
PAG
32
Private Advisor Group
New Jersey
– -$5K -194 Closed
1
2